Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.KESA Partners has acquired Bioserv, a US affiliate of NextPharma Technologies, for an undisclosed sum.
Subscribe to our email newsletter
The sale of Bioserv will support NextPharma’s growth strategy of focusing on its core specialty and conventional product and technology operating platform in Europe.
KESA Partners managing partner Al Hansen said Bioserv has been known for its quality, flexibility and responsiveness to customers’ unique requirements.
"Bioserv is well positioned to benefit from the increased out-sourcing in the pharmaceutical industry," Hansen added.
"Bioserv has a strong foundation to build upon and to add capabilities to its current service offering
"By enhancing our capabilities and emphasizing excellence in quality and execution Bioserv will become a leader in the contract manufacturing space."